214610 — MiCo BioMed Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩71bn
- KR₩80bn
- KR₩5bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -14,639 | -5,776 | -10,585 | -38,919 | -25,795 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 3,759 | 10,033 | 5,557 | 22,195 | 15,369 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,265 | -24,712 | -6,011 | -128 | -3,243 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10,435 | -18,679 | -8,600 | -14,006 | -11,359 |
Capital Expenditures | -1,423 | -6,022 | -3,131 | -1,661 | -681 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 4,164 | -3,705 | -9,464 | -10,867 | -7,883 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 2,741 | -9,727 | -12,595 | -12,528 | -8,565 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 11,157 | 39,789 | 23,733 | 8,327 | 23,587 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3,479 | 11,250 | 2,956 | -18,133 | 3,676 |